These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer. Naya Y, Fritsche HA, Bhadkamkar VA, Mikolajczyk SD, Rittenhouse HG, Babaian RJ. Urology; 2004 Mar; 63(3):492-8. PubMed ID: 15028444 [Abstract] [Full Text] [Related]
8. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer. Ozdal OL, Aprikian AG, Bégin LR, Behlouli H, Tanguay S. BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145 [Abstract] [Full Text] [Related]
10. Is there a role for serum human tissue kallikrein in detection of prostate cancer? Ochiai A, Shukla A, Davis JW, Fritsche HA, Bhadkamkar V, Babaian RJ. Urology; 2007 Sep; 70(3):519-22. PubMed ID: 17905108 [Abstract] [Full Text] [Related]
11. [Analysis of reference range responsible to normal percent value of free prostate specific antigen from men without prostate disease]. Zhang P, Wang ZM, Chong T, Zhao LH. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):871-3, 903. PubMed ID: 17953381 [Abstract] [Full Text] [Related]
13. Serum insulin-like growth factor I/free prostate specific antigen (IGF-I/fPSA) ratio enhances prostate cancer detection in men with total PSA 4.0-10.0 ng/ml. Zhigang Z, Jieming L, Su L, Wenlu S. J Surg Oncol; 2007 Jul 01; 96(1):54-61. PubMed ID: 17345593 [Abstract] [Full Text] [Related]
17. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Guazzoni G, Lazzeri M, Nava L, Lughezzani G, Larcher A, Scattoni V, Gadda GM, Bini V, Cestari A, Buffi NM, Freschi M, Rigatti P, Montorsi F. Eur Urol; 2012 Mar 01; 61(3):455-66. PubMed ID: 22078333 [Abstract] [Full Text] [Related]
18. [Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)]. Tsuchiya N, Ohyama C, Habuchi T. Gan To Kagaku Ryoho; 2005 Feb 01; 32(2):275-80. PubMed ID: 15751649 [Abstract] [Full Text] [Related]
19. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ, Rittenhouse HG, Kadmon D, Miles BJ, Slawin KM. Urology; 2004 May 01; 63(5):905-10; discussion 910-1. PubMed ID: 15134977 [Abstract] [Full Text] [Related]
20. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings. Inahara M, Suzuki H, Kojima S, Komiya A, Fukasawa S, Imamoto T, Naya Y, Ichikawa T. Urology; 2006 Oct 01; 68(4):815-9. PubMed ID: 17070359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]